TBZF can engage various cellular mechanisms to prompt its activation. Forskolin, for instance, directly targets adenylyl cyclase to increase intracellular cAMP levels, paving the way for the phosphorylation of TBZF. Similarly, Isoproterenol, a beta-adrenergic agonist, also raises cAMP through G protein-coupled receptor signaling, which is another route leading to TBZF's activation. On the same pathway, IBMX contributes by inhibiting the breakdown of cAMP by phosphodiesterases, ensuring that cAMP levels remain elevated, which is crucial for the activation of TBZF. Dibutyryl-cAMP, a cAMP analog, activates PKA, which then triggers a cascade of downstream signaling events. These events orchestrate a conducive environment for the activation of TBZF. Additionally, Phorbol 12-myristate 13-acetate (PMA) leverages the protein kinase C (PKC) route, which can phosphorylate TBZF within intracellular signaling networks.
Anisomycin, through its role as a protein synthesis inhibitor, activates stress-activated protein kinases, which may also facilitate the activation of TBZF. Thapsigargin operates by disrupting calcium homeostasis through the inhibition of the SERCA pump, resulting in raised intracellular calcium levels that activate calcium-dependent pathways, indirectly supporting the activation of TBZF. Ionomycin similarly increases intracellular calcium, potentially triggering calmodulin-dependent kinases that could lead to the activation of TBZF. Retinoic acid can engage nuclear receptors, which may influence TBZF-regulated gene promoters, leading to TBZF's activation through transcriptional co-regulation. The role of growth factors such as Epidermal Growth Factor (EGF) and Insulin in TBZF activation is mediated via their respective receptor tyrosine kinases and the PI3K/Akt signaling pathway, both of which are known to result in downstream phosphorylation events that include the activation of TBZF. Lastly, A23187 serves as a calcium ionophore, boosting intracellular calcium levels and potentially contributing to the activation of TBZF through calcium-dependent signaling mechanisms. Each of these chemicals provides a distinct molecular avenue to orchestrate the activation of TBZF through direct interaction with its regulatory mechanisms.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP through G protein-coupled receptor signaling, which can result in the activation of TBZF. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP breakdown, which maintains cAMP levels high, thus contributing to the activation of TBZF. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate and activate TBZF as part of intracellular signaling cascades. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation stimulates PI3K/Akt signaling pathway that can lead to the subsequent phosphorylation and activation of TBZF. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase and potentially lead to the activation of TBZF. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases, which may lead to the activation of TBZF. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting the SERCA, which can activate pathways leading to the activation of TBZF. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can activate nuclear receptors that may interact with TBZF-regulated gene promoters, leading to its activation through transcriptional co-regulation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, leading to downstream signaling events that can include the activation of TBZF. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, raising intracellular calcium levels, potentially leading to the activation of TBZF through calcium-dependent pathways. | ||||||